Who owns NAUTILUS BIOTECHNOLOGY INC?
- Ticker: NAUT
- CUSIP Number: 63909j108
Tip: Access positions for across all investors
Analyze quarterly positions in Nautilus Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Nautilus Biotechnology stock
Who bought or sold NAUTILUS BIOTECHNOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AH Capital Management | 18M | $34M | 0% | Dec 2025 |
|
| Perceptive Advisors | 13M | $11M | 0% | Sep 2025 |
|
| Cercano Management | 7.2M | $14M | 0% | Dec 2025 |
|
| Madrona Venture Group | 6.0M | $12M | 0% | Dec 2025 |
|
| Vanguard Group | 2.6M | $5.1M | 7% | Dec 2025 |
|
| Comprehensive Financial Management | 2.2M | $4.3M | 0% | Dec 2025 |
|
| Amazon | 1.5M | $2.8M | 0% | Dec 2025 |
|
| Clarius | 1.2M | $2.4M | 0% | Dec 2025 |
|
| Millennium Management | 968k | $818k | -8% | Sep 2025 |
|
| _Sentinel Trust Company, LBA______________ | 750k | $1.5M | 100% | Dec 2025 |
|
| Tikvah Management | 727k | $1.4M | 0% | Dec 2025 |
|
| Acadian Asset Management | 612k | $1.2M | 152% | Dec 2025 |
|
| Geode Capital Management | 561k | $1.1M | 1% | Dec 2025 |
|
| Goldman Sachs Group | 297k | $580k | 153% | Dec 2025 |
|
| Dimensional Fund Advisors | 285k | $557k | -22% | Dec 2025 |
|
| Renaissance Technologies | 260k | $507k | -74% | Dec 2025 |
|
| Citadel Advisors | 254k | $215k | -24% | Sep 2025 |
|
| Alyeska Investment Group | 254k | $494k | 0% | Dec 2025 |
|
| Jane Street | 207k | $403k | 40% | Dec 2025 |
|
| State Street Corporation | 201k | $392k | 13% | Dec 2025 |
|
| Hillman | 200k | $390k | 0% | Dec 2025 |
|
| BlackRock | 189k | $369k | -6% | Dec 2025 |
|
| Crewe Advisors | 136k | $265k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 125k | $106k | 0% | Sep 2025 |
|
| GSA Capital Partners | 124k | $242k | -52% | Dec 2025 |
|
| Qube Research & Technologies | 123k | $240k | 138% | Dec 2025 |
|
| Marshall Wace | 117k | $228k | 100% | Dec 2025 |
|
| CI Private Wealth | 115k | $224k | -64% | Dec 2025 |
|
| Northern Trust | 107k | $209k | -9% | Dec 2025 |
|
| OMERS Administration Corporation | 105k | $204k | 100% | Dec 2025 |
|
| Point72 Asset Management | 61k | $119k | 100% | Dec 2025 |
|
| Hsbc Holdings | 50k | $40k | 0% | Sep 2025 |
|
| Barclays | 48k | $94k | 0% | Dec 2025 |
|
| Ashton Thomas Private Wealth | 45k | $88k | 0% | Dec 2025 |
|
| Fayez Sarofim & Co | 45k | $88k | 0% | Dec 2025 |
|
| Caprock | 44k | $86k | 158% | Dec 2025 |
|
| Susquehanna International | 43k | $84k | 100% | Dec 2025 |
|
| Palumbo Wealth Management | 41k | $80k | -2% | Dec 2025 |
|
| Lighthouse Investment Partners | 40k | $78k | 100% | Dec 2025 |
|
| Presidio Capital Management | 35k | $68k | 0% | Dec 2025 |
|
| Captrust Financial Advisors | 34k | $66k | 100% | Dec 2025 |
|
| XTX Topco | 34k | $66k | -26% | Dec 2025 |
|
| Badgley Phelps Wealth Managers | 30k | $59k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 28k | $54k | 1792% | Dec 2025 |
|
| Callan Family Office | 26k | $51k | 75% | Dec 2025 |
|
| Virtu Financial | 24k | $46k | 20% | Dec 2025 |
|
| Hudson Bay Capital Management | 19k | $37k | 100% | Dec 2025 |
|
| Garde Capital | 18k | $35k | 100% | Dec 2025 |
|
| Point72 Asia | 16k | $14k | -50% | Sep 2025 |
|
| Two Sigma Securities | 16k | $32k | 100% | Dec 2025 |
|
| FNY Investment Advisers | 14k | $27k | 0% | Dec 2025 |
|
| Vanguard Capital Wealth Advisors | 13k | $25k | -4% | Dec 2025 |
|
| Squarepoint Ops | 11k | $22k | -91% | Dec 2025 |
|
| FMR | 8.7k | $7.3k | -65% | Sep 2025 |
|
| UBS Group | 5.2k | $10k | 999% | Dec 2025 |
|
| Rockefeller Capital Management | 5.0k | $9.8k | 0% | Dec 2025 |
|
| Group One Trading | 3.9k | $7.6k | 100% | Dec 2025 |
|
| Jpmorgan Chase & Co | 2.1k | $1.8k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 1.8k | $0 | -21% | Sep 2025 |
|
| TD Waterhouse Canada | 1.0k | $1.9k | 0% | Dec 2025 |
|
| Point72 | 789.00 | $667.020600 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 715.00 | $1.4k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 560.00 | $1.1k | 0% | Dec 2025 |
|
| Guerra Advisors | 400.00 | $338.000000 | 100% | Sep 2025 |
|
| Your Advocates | 150.00 | $292.995000 | 0% | Dec 2025 |
|
| CWM | 55.00 | $0 | -70% | Dec 2025 |
|
| EverSource Wealth Advisors | 49.00 | $96.000800 | -79% | Dec 2025 |
|
| Optiver Holding B.V. | 40.00 | $78.000000 | 0% | Dec 2025 |
|
| Covestor | 8.00 | $0 | 0% | Dec 2025 |
|
| Tower Research Capital | 5.00 | $10.000000 | -100% | Dec 2025 |
|
| Cubist Systematic Strategies | 1.00 | $1.000000 | -100% | Sep 2025 |
|
Who sold out of Nautilus Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jacobs Levy Equity Management | Sep 2025 | 301k | $254k |
| AQR Capital Management | Jun 2025 | 42k | $31k |
| Aventura Private Wealth | Sep 2025 | 350.00 | $295.995000 |
| SRS Capital Advisors | Sep 2025 | 148.00 | $125.000800 |
| Cloud Capital Management | Sep 2025 | 49.00 | $0 |
| True Wealth Design | Sep 2025 | 17.00 | $15.000800 |